Registered entities
Denovo Biopharma Llc
Reg. No. 471304346United States
Innovation
13 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,129 times.
| Year | Filings |
|---|---|
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
Social engagement
Social engagement: 3K social following, 7 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Zhejiang Xianju Pharmaceutical, Guangzhou Yuexiu Industrial Investment Fund Management, Goldstone Investment , Jiuyou Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 21% |
| Private equity | 2 | 14% |
| Bank & private debt | 2 | 14% |
| Other / undisclosed | 7 | 50% |
Recent activity
20 Feb 2026
Event
Oppenheimer Healthcare Conference
5 Jan 2026
Partnership
Denovo Neuroscience
30 Oct 2025
Event
Well Fargo Private Biopharma Symposium